Introduction
In a recent Journal of Perinatal Medicine, HOCHULI et al, [2] state that there is no doubt that intranatal monitoring iseffective and that the reduction of perinatal mortality amply demonstrates this. The authors quote 14 articles to support this Statement. None of the series quoted give more than circumstantial evidence based upon the coincidence of a reduction of mortality with the introduction of intranatal monitoring and this does not exclude the possibility of other factors contributing partiaUy or wholly to the decline in perinatal mortality. The following may influence perinatal mortality: Social characteristics of the population, general health of the obstetric population, clinical expertise of staff and Organisation of obstetrics Services. The authors of the papers concerned with intranatal monitoring were unable to exclude the possibility of one or more of these factors causing the decline of perinatal mortality. Only properly controlled prospective trials can test the efficacy of newly introduced techniques. Two randomised controlled trials testing the efficacy of intranatal monitoring have been completed; unfortunately, the results differed [2, 3] . Therefore the value of fetal monitoring is not äs clear cut äs HOCHULI and other authors claim. The purpose of the present article is to compare the two controlled trials and to determine, if possible, why the results differed.
Material and Methods
The two control trials are compared in Tab. I. In both studies, care was taken to ensure that the patients in monitored and control groups were similar. However, the Systems used for matching patients were different. The clinical condition of fetuses in the monitored and control groups may have been different. In the American trial there was an adverse loading in the monitored group early in labour, äs judged by abnormalities of fetal heart rate recordings. In the Australian trial, the fetuses could not be compared äs the control group was not monitored. The problem of whether there were differences of obstetric care during labour were discussed in the reports of both studies. In the American study, nursing care was increased in the control group and this was thought to be due to a compensatory reaction of the nursing staff, trying to improve care in the control group. In the Australian study, observations by those not involved in the trial suggested that the quality of medical and nursing care was similar in the control and monitored groups; both the medical and nursing staff were interested in the outcome of the trial and were asked to avoid bias towards one or other group. The criteria for Intervention was different in the two studies. In the American study, HON and KUBLI'S fetal heart rate classification was used and action taken according to the abnormalities defmed by this classification. In the Australian study, fetal heart rate abnormality was defmed by a simpler fetal heart rate classification and when abnormalities were presep,t, fetal scalp pH was carried out. Action taken in both studies differed. In the American study, the incidence of Caesarean section was higher in the monitored group, whereas in the Australian study this was not so. In the American Study, perinatal morbidity, cord pH and neonatal intensive care were similar in the control and monitored group, whereas in the Australian study, perinatal morbidity and the incidence of neonatal intensive care were higher in the control group, and the cord pH was higher in the monitored group. These differences were statistically significant. Indices of neonatal condition have been rearranged in order to compare the outcome of the studies Tab. II. Comparison of the two trials show differences. The monitored group in the Australian study had less neonatal complications than any of the other three groups. However, the control group of HA VERKAMP et al.
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[1], fared better than the control group of the Australian study. There were four infants in the Australian study control group who were suffering from brain damage 6 months after birth.
Discussion
A number of reasons may explain the differences in the results of the two trials.
(1) The patients admitted into the two trials may have differed. (2) There may have been differences in the number of sick fetuses in the control and monitored groups at the commencement of each trial. Because of the matching of so many variables in the Australian study this seems unlikely but the fact thatinearlylabour the American study demonstrated a difference in the numbers of abnormal fetal heart rate recordings in the control and monitored groups suggests this possibility cannot be excluded. (3) Better clinical care of the control group was thought possible in the American study although it was unlikely to have influenced the Australian study. (4) Differences between the two studies existed in the criteria for judging abnormal fetal heart rate and the action taken subsequent to this. The Australian study had the advantage of scalp blood pH measurements. (5) The general health and/or obstetric care of the control group in the American study may have been better than that of the control group in the Australian study. Four infants suffered brain damage in the Australian control group. Nevertheless, using other neonatal indices, the number of unhealthy babies in both control groups were similar.
The limitations of each study have been discussed fully. Nevertheless, the studies still may indicate the conditions under which fetal intensive care is valuable. When a controlled trial produces a positive result, it is important to know that the fetal condition of both control and monitored groups are comparable äs judged by an equal incidence of fetal heart rate abnormalities. This Information was not available in the Australian study äs clinicians considered that the results of fetal heart rate recordings in the control group may be communicated to the doctor in Charge of the patient's management by nurses or residente or technicians, either overtly or subconsciously. However, the American study overcame this problem by hiding the fetal heart rate recordings from all personnel; the exact mechanism by which this was achieved is not clear but this is an important consideration for any future study. If a controlled trial produces a negative result, there being no differences between the monitored and control groups, then it is important to determine whether the condition of the fetuses in the two groups were comparable at the commencement of the trial (fetal heart rate, scalp pH), whether the diagnostic tests have been properly done and properly interpreted, and whether appropriate clinical action has been taken.
It is important for further control studies to be done to define the conditions under which fetal intensive care is effective. It seems feasible that in some population samples, where the general health of the patient is good, few obstetric complications occur, general obstetric clinical Standards are high and the obstetric Services are well organised, that a negative result may occur. However, it seems equally likely, that in the absence of any of these favourable circumstances, that a positive result may occur. In order to aid administrators of health care decide where to place fetal intensive care units and how to run obstetric Services economically, the conditions under which monitoring is effective has to be determined in more detail. The different results of the two controlled trials suggest that the coincidence of reduction in perinatal mortality and the introduction of fetal monitoring is insufficient evidence to base the introduction of fetal monitoring to all patients. Sometimes it is difficult to organise control trials. Obstetric personnel may consider trials are unnecessary äs they already believe they know what is correct. It is difficult to argue the ethical merits of trials -one group may be convinced that to withold a new test or treatment is unethical, while another group may be convinced that to try a new method is unethical. Another problem in the Organisation of controlled trials is the difficulty in obtaining informed consentof the patient. Patients may defer from a trial because they prefer either traditional or new care. Because of such difficulties, the possibility of reaching conclusions from perinatal mortality statistics remains. The limitations of Interpretation of perinatal mortality statistics have been mentioned. However, under specified circumstances this Information may be helpful. In order to draw valid conclusions from mortality data the following criteria for judging a change in mortality to be causally related to some other event, such äs monitoring, may be helpful. The time sequence between the change in mortality and the introduction and rate of use of monitoring must be correct; there must be a consistency of this association in different studies; the degree of change of mortality and the type of change in mortality should be consistent with that expected from monitoring; and there should be a coherent explanation of a causal nature in how the monitoring effected mortality. In our own hospital there was a decline in the intrapartum anoxic stillbirths of mature fetuses over a period of time. While this change may undoubtedly be due to factors such äs improvement of the obstetric health of the population, the Standard of clinical care and the organistation of the obstetric Services, the possibility of a relationship with the introduction of fetal diagnostic tests is suggested by the finding that \the major change in mortality occurred at the time of the introduction of the tests, and in mature fetuses dying of intrapartum anoxia (Fig. 1) . Nevertheless, the randomised controlled trial remains the best available method of testing the effect of new therapeutip regimes. In one controlled trial neonatal condition was better in the monitored than the control group. This was thought to result from the more accurate diagnosis of fetal distress by means of fetal heart rate monitoring and fetal scalp blood pH measurement rather than other factors involved in the trial. In the other controlled trial no difference in the neonatal morbidity was found between the monitored and control group. This was thought to be due to the high Standard of general obstetric care in the control group but other factors such äs the absence of scalp sampling in the monitored group and compensatory care in the control group (auscultation of FBR at very frequent intervals), could not be excluded. In the positive controlled trial, the neonatal morbidity of the monitored and control group s was higher and lower respectively, than either of the groups in the negative controlled study. This suggests that monitoring is effective but the benefits depend upon the general Standard of obstetric care. When general health of the populatiön is good, few obstetric complications occur and obstetric care is of a high Standard then monitoring may not be beneficial. However, in the absence of any of these favourable circumstances, monitoring may be beneficial. Further controlled trials need to be carried out taking into account the limitations of the current trials and the need to define more clearly which obstetric patients may benefit from monitoring.
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